Eli Lilly to acquire Adverum Biotechnologies and expand gene therapy portfolio with Ixo-vec EP News Bureau Oct 27, 2025 The acquisition will add Adverum’s intravitreal gene therapy programme for wet age-related macular degeneration to Lilly’s…
EyePoint’s Duravyu holds potential to become new treatment option for wAMD: GlobalData EP News Bureau Jun 4, 2025 Sustained-release implant Duravyu may reduce treatment burden in wet AMD patients while maintaining efficacy and durability
